The FDA Drug Development Process – an NF interpretation in Mold

“Take better care of your health, please, please,” cautioned Blazing Night.
“I’m trying to,” said Rob.
“You’re not trying hard enough,” advised Blazing Night.

Blue Earth Water

The U.S. Food an Drug Administration (FDA) drug development process is presented here in a Naturalistic Fantasy (NF) Mold dialect:

discovery and development + preclinical 0.1% move to the next phase over several years + clinical PhaseOne 70% move to the next phase over several months, and then 33% in PhaseTwo over several months to two years, and then 25% to 30% in PhaseThree over 1 to 4 years + review 6 to 10 months + monitoring

or on average:

discovery and development + preclinical + clinical + review + monitoring: 1 drug out of 5,000 make to market over 12 years

20151221_112237

 
What about treatment, which can only be tested on humans?

discovery and development + clinical + review + monitoring?

Inducing emotions and measuring the results?

Music, art, reading, film watching or game playing?

Patient caring in hospital, home or virtual space?

 
ACKNOWLEGDMENT

U.S. Food an Drug Administration: The Drug Development Process
Wikipedia as of January 15, 2016: Experimental cancer treatment, Oncology
Blazing Scribbles, J.M.K. Walkow, ISBN 9780986656460
Blue Earth – The Body, J.M.K. Walkow, ISBN 9780986656446
Naturalistic Fantasy, J.M.K. Walkow, ISBN 9780986656422
Blazing Night, J.M.K. Walkow, ISBNs 9780986656415, 9780986656408

Advertisements